IL158303A0 - Method for producing protein in an immortalized cell - Google Patents

Method for producing protein in an immortalized cell

Info

Publication number
IL158303A0
IL158303A0 IL15830397A IL15830397A IL158303A0 IL 158303 A0 IL158303 A0 IL 158303A0 IL 15830397 A IL15830397 A IL 15830397A IL 15830397 A IL15830397 A IL 15830397A IL 158303 A0 IL158303 A0 IL 158303A0
Authority
IL
Israel
Prior art keywords
immortalized cell
producing protein
protein
producing
immortalized
Prior art date
Application number
IL15830397A
Other languages
English (en)
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of IL158303A0 publication Critical patent/IL158303A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • C12N15/867Retroviral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/04Immortalised cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16651Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12051Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL15830397A 1996-08-13 1997-08-13 Method for producing protein in an immortalized cell IL158303A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/696,200 US5672485A (en) 1996-08-13 1996-08-13 Immortalized cell lines for virus growth
PCT/US1997/014384 WO1998006824A1 (en) 1996-08-13 1997-08-13 Immortalized cell lines for virus growth
IL12851197A IL128511A (en) 1996-08-13 1997-08-13 Rows of immortal cells for virus growth

Publications (1)

Publication Number Publication Date
IL158303A0 true IL158303A0 (en) 2004-05-12

Family

ID=24796108

Family Applications (4)

Application Number Title Priority Date Filing Date
IL15830397A IL158303A0 (en) 1996-08-13 1997-08-13 Method for producing protein in an immortalized cell
IL15830297A IL158302A0 (en) 1996-08-13 1997-08-13 A method for producing recombinant virus
IL15830197A IL158301A0 (en) 1996-08-13 1997-08-13 Method for growing virus
IL12851197A IL128511A (en) 1996-08-13 1997-08-13 Rows of immortal cells for virus growth

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL15830297A IL158302A0 (en) 1996-08-13 1997-08-13 A method for producing recombinant virus
IL15830197A IL158301A0 (en) 1996-08-13 1997-08-13 Method for growing virus
IL12851197A IL128511A (en) 1996-08-13 1997-08-13 Rows of immortal cells for virus growth

Country Status (29)

Country Link
US (4) US5672485A (es)
EP (1) EP0920491B1 (es)
JP (3) JP3754088B2 (es)
KR (1) KR100375871B1 (es)
CN (1) CN1228119B (es)
AR (1) AR008294A1 (es)
AT (1) ATE362524T1 (es)
AU (1) AU726820B2 (es)
BR (1) BR9711067A (es)
CA (1) CA2263725C (es)
CO (1) CO4700552A1 (es)
DE (1) DE69737735T2 (es)
DK (1) DK0920491T3 (es)
DZ (1) DZ2291A1 (es)
ES (1) ES2285738T3 (es)
GT (1) GT199700091A (es)
HK (1) HK1022496A1 (es)
HN (1) HN1997000124A (es)
HU (1) HU226658B1 (es)
IL (4) IL158303A0 (es)
MA (1) MA24303A1 (es)
MY (1) MY125594A (es)
NZ (1) NZ334147A (es)
PE (1) PE108198A1 (es)
PT (1) PT920491E (es)
SV (1) SV1997000071A (es)
UY (1) UY24668A1 (es)
WO (1) WO1998006824A1 (es)
ZA (1) ZA977216B (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
US6150505A (en) * 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6821741B1 (en) * 2001-04-27 2004-11-23 University Hospitals Of Cleveland Cells for detection of enteroviruses
US6552172B2 (en) 2001-08-30 2003-04-22 Habto Biotech, Inc. Fibrin nanoparticles and uses thereof
US20040023358A1 (en) * 2001-12-21 2004-02-05 Wyeth Avian embryo particulate biomass for the production of virus antigens
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
US20090217404A1 (en) * 2002-09-27 2009-08-27 Lowe Scott W Cell-based RNA interference and related methods and compositions
US7410557B2 (en) * 2002-09-30 2008-08-12 Honda Motor Co., Ltd. Hydrogen activating apparatus
EP1572985A4 (en) * 2002-12-13 2008-03-19 Aventis Pasteur Inc ALVAC PRODUCTION ON AVIAN STEM CELLS
US20090186839A1 (en) * 2003-02-17 2009-07-23 Cold Spring Harbor Laboratory Model for studying the role of genes in chemoresistance
CA2516022C (en) * 2003-02-17 2012-05-29 Cold Spring Harbor Laboratory Model for studying the role of genes in tumor resistance to chemotherapy
US20040255345A1 (en) * 2003-03-07 2004-12-16 Rapp Jeffrey C. Production of transgenic avians
US20050198700A1 (en) * 2003-03-07 2005-09-08 Avigenics, Inc. Genomic modification
WO2004080162A2 (en) * 2003-03-07 2004-09-23 Avigenics, Inc. Integrase mediated avian transgenesis
US20050273873A1 (en) * 2003-03-07 2005-12-08 Avigenics, Inc. Genomic modification
US20050034186A1 (en) * 2003-03-07 2005-02-10 Harvey Alex J. Site specific nucleic acid integration
ATE467678T1 (de) 2003-07-22 2010-05-15 Vivalis Produktion von poxviren mit adhärenten oder nicht adhärenten vogelzellinien
US20070275010A1 (en) * 2003-09-18 2007-11-29 Mark Feinberg Mva Vaccines
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
US20060174364A1 (en) * 2004-03-01 2006-08-03 Avigenics, Inc. Artificial chromosomes and transchromosomic avians
US20060123504A1 (en) * 2004-12-07 2006-06-08 Avigenics, Inc. Methods of producing polyclonal antibodies
WO2006042214A1 (en) * 2004-10-08 2006-04-20 Avigenics, Inc. Modified integrase and methods of use
US8137907B2 (en) * 2005-01-03 2012-03-20 Cold Spring Harbor Laboratory Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
US20070044164A1 (en) 2005-05-31 2007-02-22 Cold Spring Harbor Laboratory Methods for producing microRNAs
AU2006302640B2 (en) * 2005-10-05 2010-08-19 Synageva Biopharma Corp. Rapid production of high titer virus
EP2530161B1 (en) 2006-06-20 2018-03-28 Transgene SA Process for producing poxviruses and poxvirus compositions
CN100443588C (zh) * 2006-12-11 2008-12-17 中国农业科学院北京畜牧兽医研究所 静宁鸡胚成纤维细胞系及其培养方法
US8213704B2 (en) * 2007-05-09 2012-07-03 Kla-Tencor Corp. Methods and systems for detecting defects in a reticle design pattern
EP2014279A1 (en) * 2007-06-22 2009-01-14 Pevion Biotech AG Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
US8357531B2 (en) 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
KR101528379B1 (ko) 2007-07-03 2015-06-16 트랜스진 에스.에이. 불멸화된 조류 세포주들
WO2009055724A2 (en) * 2007-10-26 2009-04-30 Cold Spring Harbor Laboratory High throughput methods for functionally determining rna interference efficiency
US8865450B2 (en) 2008-02-25 2014-10-21 Baxter International Inc. Method for producing continuous cell lines
BRPI1007743A2 (pt) * 2009-05-12 2017-09-19 Transgene Sa Linhagens de célula aviária imortalizada, usos de uma linhagem de célula aviária imortalizada, métodos para a produção de vírus e métodos para a produção de proteína
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
DK2596099T3 (da) 2010-07-20 2020-02-24 Bavarian Nordic As Fremgangsmåde til høst af ekspressionsprodukter
FR3008992A1 (fr) * 2013-07-25 2015-01-30 Agronomique Inst Nat Rech Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires
CN107206063B (zh) 2014-12-01 2021-09-28 特兰斯吉恩股份有限公司 稳定的液体痘苗病毒制剂
RU2694318C2 (ru) 2014-12-04 2019-07-11 Интервет Интернэшнл Б.В. Иммортализованные фибробласты эмбриона цыпленка
KR101768581B1 (ko) * 2015-08-13 2017-08-17 전북대학교 산학협력단 자발적 불멸화된 체세포의 단일 세포로부터 리프로그래밍 세포주의 제조방법
WO2017097983A1 (en) * 2015-12-11 2017-06-15 Intervet International B.V. Immortalised chicken embryonic epithelial kidney cells
WO2017191147A1 (en) 2016-05-04 2017-11-09 Transgene Sa Combination therapy with cpg tlr9 ligand
US20190328869A1 (en) 2016-10-10 2019-10-31 Transgene Sa Immunotherapeutic product and mdsc modulator combination therapy
WO2018093903A1 (en) 2016-11-17 2018-05-24 Regents Of The University Of Minnesota Immortalized cell lines and methods of use
CA3061678A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
CA3062549A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
KR20240113607A (ko) 2017-06-21 2024-07-22 트랜스진 개인 맞춤형 백신
CN107858323B (zh) * 2017-11-08 2020-10-09 广东省生物资源应用研究所 一种红耳龟胚胎成纤维细胞系及其构建方法
CN109234239B (zh) * 2018-07-13 2021-09-14 广东永顺生物制药股份有限公司 一种鸭瘟病毒的培养方法
EP3847246A1 (en) 2018-09-06 2021-07-14 Bavarian Nordic A/S Storage improved poxvirus compositions
MX2022007579A (es) 2019-12-20 2022-07-19 Intervet Int Bv Vacuna de vector hvt multivalente.
MX2022011071A (es) 2020-03-12 2022-09-23 Bavarian Nordic As Composiciones que mejoran la estabilidad del poxvirus.
TW202217002A (zh) 2020-07-13 2022-05-01 法商傳斯堅公司 免疫抑制之治療
MX2023002674A (es) 2020-09-07 2023-04-03 Intervet Int Bv Vacuna del tallo de ha para blancos positivos a anticuerpos ha.
US20240058436A1 (en) 2020-12-24 2024-02-22 Intervet Inc. Multivalent hvt vector vaccine
MX2024000544A (es) 2021-07-13 2024-04-09 Intervet Int Bv Superacion de la interferencia de los anticuerpos en las aves.
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
WO2023213946A1 (en) 2022-05-05 2023-11-09 Intervet International B.V. New multivalent hvt vector vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3058438B2 (ja) * 1990-10-19 2000-07-04 財団法人化学及血清療法研究所 ヒト肝臓組織特異的ウイルスの感染可能な霊長類の不死化肝細胞およびその調製方法
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth

Also Published As

Publication number Publication date
PT920491E (pt) 2007-07-27
CO4700552A1 (es) 1998-12-29
PE108198A1 (es) 1999-01-21
CA2263725A1 (en) 1998-02-19
UY24668A1 (es) 1998-02-02
US5985642A (en) 1999-11-16
HK1022496A1 (en) 2000-08-11
JP2006320328A (ja) 2006-11-30
KR20000029968A (ko) 2000-05-25
DK0920491T3 (da) 2007-09-17
BR9711067A (pt) 1999-08-17
ES2285738T3 (es) 2007-11-16
HU226658B1 (en) 2009-06-29
DE69737735T2 (de) 2008-01-31
GT199700091A (es) 1997-08-12
US5672485A (en) 1997-09-30
US6207415B1 (en) 2001-03-27
MY125594A (en) 2006-08-30
CN1228119A (zh) 1999-09-08
KR100375871B1 (ko) 2003-03-10
HUP0000188A2 (hu) 2000-06-28
EP0920491A1 (en) 1999-06-09
JP3754088B2 (ja) 2006-03-08
AU726820B2 (en) 2000-11-23
IL158301A0 (en) 2004-05-12
AR008294A1 (es) 1999-12-29
US5879924A (en) 1999-03-09
ATE362524T1 (de) 2007-06-15
AU4069197A (en) 1998-03-06
CA2263725C (en) 2002-10-15
IL158302A0 (en) 2004-05-12
WO1998006824A1 (en) 1998-02-19
ZA977216B (en) 1998-02-19
HUP0000188A3 (en) 2005-11-28
CN1228119B (zh) 2012-04-04
HN1997000124A (es) 1999-03-19
IL128511A (en) 2004-06-01
DZ2291A1 (fr) 2002-12-25
MA24303A1 (fr) 1998-04-01
JP2000516095A (ja) 2000-12-05
SV1997000071A (es) 2000-07-06
JP2005118053A (ja) 2005-05-12
EP0920491B1 (en) 2007-05-16
IL128511A0 (en) 2000-01-31
NZ334147A (en) 2000-08-25
DE69737735D1 (de) 2007-06-28

Similar Documents

Publication Publication Date Title
IL158303A0 (en) Method for producing protein in an immortalized cell
IL133111A0 (en) Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
IL129694A0 (en) Method for rupturing microalgae cells
EP0883339A4 (en) CELL CULTURE DEVICE AND METHOD
EP0848435A4 (en) CELL AND METHOD FOR THE PRODUCTION THEREOF
AU2247699A (en) Cell control method and apparatus
AU4718897A (en) Method and apparatus for determining virtual cell area
AU2222097A (en) Pretreatment process in flour milling method
AU1367499A (en) Method and apparatus for producing karyotypes
AU5116596A (en) Cell culture method
AU7209496A (en) Method for making an electrochemical cell, and resulting electrochemical cell
IL128512A (en) Method for immortalizing cells
AU6468398A (en) Methods for producing polypeptides in respiratory-deficient cells
EP0795027A4 (en) IN VITRO SYNTHESIS OF PROTEINS
AU2616095A (en) Method for introducing foreign matter into higher eukaryotic cells
GB9605453D0 (en) Cultured cells
SG89265A1 (en) Method and system for molding
AU2335497A (en) Method for analyzing ammonia in water
SG52565A1 (en) In service vulcanizing membrane and method for making same
IL113641A0 (en) An electrochemical cell
GB9705744D0 (en) Methods for selecting cells and their uses
GB2312960B (en) Electrochemical process
GB2322322B (en) Method and apparatus for making lead-acid batteries
HUP0102697A3 (en) Method of making proteins in transformed yeast cells
EP0927765A4 (en) METHOD FOR SELECTION OF TRANSFORMED CELLS

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired